Amatuximab

Amatuximab structure

Synonyms: Amatuximab;Amatuximab (anti-MSLN);Research Grade Amatuximab(DHG52002)

Last updated:2022-12-21 16:56:50

Amatuximab Properties

FDA UNII	6HP0354G04
NCI Drug Dictionary	amatuximab

Amatuximab is a chimeric monoclonal antibody designed for the treatment of cancer.It was developed by Morphotek, Inc.

Amatuximab is a monoclonal antibody that binds to mesothelin (a protein that is made by some cancer cells) and stops the cells from dividing.

Global( 9)Suppliers

Supplier	Tel	Email	Country	ProdList	Advantage
Hangzhou MolCore BioPharmatech Co.,Ltd.	+86-057181025280; +8617767106207	sales@molcore.com	China	49739	58
Aladdin Scientific	+1-833-552-7181	sales@aladdinsci.com	United States	57511	58
ShangHai Biochempartner Co.,Ltd	17754423994 17754423994	2853530910@QQ.com	China	8011	62
Wuhan Chemstan Biotechnology Co., Ltd.	15926423062	422450190@qq.com	China	10132	58
AntibodySystem	027-65279366 18162686757	biolab-reagents@atagenix.com	China	9790	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	4954	58
Shanghai Aladdin Biochemical Technology Co.,Ltd.	+86-18521732826	market@aladdin-e.com	China	48617	58
Shanghai jerryxing Biomedical Technology Co., Ltd	17721492509	643638326@qq.com	China	5347	58
Changsha Fuzhen Biotechnology Co.，LTD	0731-18670069958 18670069958	184792226@qq.com	China	2997	58

Supplier	Advantage
Hangzhou MolCore BioPharmatech Co.,Ltd.	58
Aladdin Scientific	58
ShangHai Biochempartner Co.,Ltd	62
Wuhan Chemstan Biotechnology Co., Ltd.	58
AntibodySystem	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	58
Shanghai Aladdin Biochemical Technology Co.,Ltd.	58
Shanghai jerryxing Biomedical Technology Co., Ltd	58
Changsha Fuzhen Biotechnology Co.，LTD	58

Amatuximab Research Grade Amatuximab(DHG52002) Amatuximab (anti-MSLN) 931402-35-6